Expand this Topic clickable element to expand a topic
Skip to content
Optica Publishing Group

High contrast breast cancer biomarker imaging using upconverting nanoparticles

Not Accessible

Your library or personal account may give you access

Abstract

Breast cancer is a leading cause of death in women and has scope for improvement in treatment stratification. We report the use of high contrast UCNP staining to distinguish different levels of HER2 expression in HER2 analyte control and HER2-positive breast cancer tissue biopsies. A contrast of 40 was found as compared to the negative control and 25 as compared to conventional DAB staining.

© 2022 The Author(s)

PDF Article
More Like This
Upconverting nanoparticles for high contrast breast cancer biomarker imaging

Sanathana Konugolu Venkata Sekar, Hui Ma, Katarzyna Komolibus, Gokhan Dumlupinar, Matthias J. Mickert, Krzysztof Krawczyk, and Stefan Andersson-Engels
JTu5A.87 Frontiers in Optics (FiO) 2023

Long-Term Live Cell Imaging of Breast Cancer Stem Cell Biomarkers Using Nanoparticle Labels

Maria Navas-Moreno, Tatyana Chernenko, Majid Mehrpouyen, Ming Yan, Demet Candas, Jian Jian Li, and James W. Chan
BT4A.5 Bio-Optics: Design and Application (BODA) 2015

Optical Biomarkers in Breast Cancer

Nimmi Ramanujam
BMA4 Biomedical Optics (BIOMED) 2008

Select as filters


Select Topics Cancel
© Copyright 2024 | Optica Publishing Group. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies.